Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Rubén
Pío Osés
Catedrático de Universidad
Rubén Pío Osés-rekin lankidetzan egindako argitalpenak (52)
2024
-
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Molecular Cancer, Vol. 23, Núm. 1
-
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
eBioMedicine, Vol. 102
2023
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
2022
-
C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d
Frontiers in Immunology, Vol. 13
-
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Cancer Letters, Vol. 529, pp. 70-84
-
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
Bioengineering and Translational Medicine, Vol. 7, Núm. 3
-
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377
-
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
DMM Disease Models and Mechanisms, Vol. 15, Núm. 1
2021
-
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer
Translational Research, Vol. 233, pp. 77-91
-
Endogenous retroelement activation by epigenetic therapy reverses the warburg effect and elicits mitochondrial-mediated cancer cell death
Cancer Discovery, Vol. 11, Núm. 5, pp. 1268-1285
-
Molecular biomarkers in early stage lung cancer
Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185
-
Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge
Frontiers in Immunology, Vol. 12
-
Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography
Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106
-
The complement system in ovarian cancer: An underexplored old path
Cancers, Vol. 13, Núm. 15
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337
2020
-
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282
-
Id1 and pd-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-l1 expression and tumor infiltrating CD8+ T cells
Cancers, Vol. 12, Núm. 11, pp. 1-22
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2019
-
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Thorax, Vol. 74, Núm. 4, pp. 371-379
-
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357